2023年第3版《NCCN肿瘤临床实践指南：非小细胞肺癌》更新解读

Lung cancer is the malignant tumor with the highest morbidity and mortality in China. Non-small cell lung cancer (NSCLC) is the main pathological subtype of lung cancer. On April 13, 2023, the National Comprehensive Cancer Network (NCCN) released the third edition of the 2023 NCCN Oncology Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHU, Lingling, WANG, Ting, WU, Juan, ZHAI, Xiaoqian, WU, Qiang, DENG, Hanyu, QIN, Changlong, TIAN, Long, ZHOU, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Guideline Interpretation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365961/
https://www.ncbi.nlm.nih.gov/pubmed/37488078
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365961/
https://www.ncbi.nlm.nih.gov/pubmed/37488078
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.18

Ejemplares similares